Literature DB >> 21396287

Management of left pancreatic trauma.

Brice Malgras1, Richard Douard, Nathalie Siauve, Philippe Wind.   

Abstract

Left pancreatic traumas (LPTs) are rare but serious lesions occurring in 1 to 6 per cent of abdominal trauma patients and mainly resulting from blunt traumas. LPT severity is primarily dependent on the associated injuries and secondarily related to main pancreatic duct injury responsible for complications: acute pancreatitis, pseudocysts, pancreatic fistulas, or abscesses. The guidelines for blunt LPT management can be presented as follows. In case of emergency laparotomy, pancreas exploration is mandatory to detect pancreatic duct lesions. In the absence of main pancreatic duct lesions, simple drainage is advocated. In case of distal injury to the main pancreatic duct, a left pancreatectomy is mandatory. In the absence of initial laparotomy, the diagnosis is more and more based on CT and magnetic resonance cholangiopancreatography, which tend to replace endoscopic retrograde cholangiopancreatography (ERCP) as a first-intent diagnostic modality. In case of distal injury to the main pancreatic duct, spleen-preserving distal pancreatectomy is recommended. In the absence of main pancreatic duct lesions, nonoperative treatment is advocated. When LPTs are discovered at the time of complications, pancreatic fistulas and/or pseudocysts are associated with main pancreatic lesions, which can be treated by pancreatic duct stenting at ERCP and/or internal endoscopic cystogastrostomy. However, in such cases, spleen-preserving distal pancreatectomy remains the treatment of choice. Pancreatic ductal lesions resulting from LPT have to be diagnosed early to avoid late complications. Distal pancreatectomy remains the treatment of choice in case of severe pancreatic ductal lesions because the role of ERCP stenting and endoscopic techniques needs further evaluation.

Entities:  

Mesh:

Year:  2011        PMID: 21396287

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  6 in total

1.  Pancreatic injury in 284 patients with severe abdominal trauma: outcome, course, and treatment algorithm.

Authors:  Matthias Heuer; Björn Hussmann; Rolf Lefering; Georg Taeger; Gernot M Kaiser; Andreas Paul; Sven Lendemans
Journal:  Langenbecks Arch Surg       Date:  2011-08-17       Impact factor: 3.445

2.  TRPV4 channel opening mediates pressure-induced pancreatitis initiated by Piezo1 activation.

Authors:  Sandip M Swain; Joelle M-J Romac; Rafiq A Shahid; Stephen J Pandol; Wolfgang Liedtke; Steven R Vigna; Rodger A Liddle
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

3.  Pancreatic injury in blunt abdominal trauma.

Authors:  Jasmin Hasanovic; Mirha Agic; Zijah Rifatbegovic; Zlatan Mehmedovic; Amra Jakubovic-Cickusic
Journal:  Med Arch       Date:  2015-04-06

4.  Evaluation of blunt pancreatic injury with contrast-enhanced ultrasonography in comparison with contrast-enhanced computed tomography.

Authors:  Qing Song; Jie Tang; Fa-Qin Lv; Yan Zhang; Zi-Yu Jiao; Qiang Liu; Yu-Kun Luo
Journal:  Exp Ther Med       Date:  2013-03-15       Impact factor: 2.447

5.  Piezo1 is a mechanically activated ion channel and mediates pressure induced pancreatitis.

Authors:  Joelle M-J Romac; Rafiq A Shahid; Sandip M Swain; Steven R Vigna; Rodger A Liddle
Journal:  Nat Commun       Date:  2018-04-30       Impact factor: 14.919

Review 6.  Duodeno-pancreatic and extrahepatic biliary tree trauma: WSES-AAST guidelines.

Authors:  Federico Coccolini; Leslie Kobayashi; Yoram Kluger; Ernest E Moore; Luca Ansaloni; Walt Biffl; Ari Leppaniemi; Goran Augustin; Viktor Reva; Imitiaz Wani; Andrew Kirkpatrick; Fikri Abu-Zidan; Enrico Cicuttin; Gustavo Pereira Fraga; Carlos Ordonez; Emmanuil Pikoulis; Maria Grazia Sibilla; Ron Maier; Yosuke Matsumura; Peter T Masiakos; Vladimir Khokha; Alain Chichom Mefire; Rao Ivatury; Francesco Favi; Vassil Manchev; Massimo Sartelli; Fernando Machado; Junichi Matsumoto; Massimo Chiarugi; Catherine Arvieux; Fausto Catena; Raul Coimbra
Journal:  World J Emerg Surg       Date:  2019-12-11       Impact factor: 5.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.